In Collaboration With

Endpoints is the biopharma and healthcare industries' trusted source for up-to-the-moment news, in-depth reporting on science and business, and coverage of the people, companies and money that drive innovation.

Global Drug Discovery Partner

Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery by combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities. We work collaboratively with our clients to meet the most complex scientific challenges, and our innovative partnerships with leading instrument makers and academic institutions help us continually expand the possibilities of human health.

Strategic Partner

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals works in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers quality solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work With Heart^TM every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. This approach continues to earn us recognition industrywide, with Parexel being the recipient of the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award for advancing the clinical research profession through strong site partnerships and named “Top CRO to Work With” by investigative sites worldwide in the 2023 WCG CenterWatch Global Site Relationship Benchmark Survey.

Associate sponsor

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe. 

Executive Connections

Rich engagement with large numbers of industry decision-makers through interactive workshops and networking

Brand Amplification

Position your brand alongside leading pharma and biotech executives

Thought Leadership

Share your views with senior leaders through a range of panel discussions and keynotes

Product Placement

Showcase your latest, innovative solutions to help the industry overcome its toughest challenges

Global Media Access

Benefit from a marketing campaign that reaches a global audience of over 100,000 industry professionals

Data & Analytics

Post-event data capture and analytics with detailed feedback on campaign promotion and on-the-day engagement

Contact Holly about Sponsorship

Holly Watson-Steward
holly.watson-steward@ft.com  

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice